Home › Geographic Atrophy › California › Los Angeles
Geographic Atrophy clinical trials in Los Angeles, CA
3 studies for Geographic Atrophy are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
RecruitingPhase 2
- USC - Keck, Los Angeles
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RecruitingPhase 3
- Kaiser Permanente Los Angeles Medical Center, Los Angeles
- Jules Stein Eye Institute in David Geffen School of Medicine at UCLA, Los Angeles
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
RecruitingPhase 1
- Jules Stein Eye Institute, Los Angeles
Geographic Atrophy trials in other cities
- Reno, NV8 studies
- Dallas, TX8 studies
- Austin, TX7 studies
- Santa Monica, CA7 studies
- Naperville, IL6 studies
- Cleveland, OH6 studies
- The Woodlands, TX6 studies
- Baltimore, MD6 studies
- Houston, TX6 studies
- St. Louis, MO5 studies
- Washington, DC5 studies
- San Antonio, TX5 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.